Journal of Nutrition EB Program 2010 Abstracts

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supporting Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seeram, N. P.
Right arrow Articles by Heber, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seeram, N. P.
Right arrow Articles by Heber, D.
© 2006 American Society for Nutrition J. Nutr. 136:2481-2485, October 2006


Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

Pomegranate Juice Ellagitannin Metabolites Are Present in Human Plasma and Some Persist in Urine for Up to 48 Hours1,2

Navindra P. Seeram3,*, Susanne M. Henning3, Yanjun Zhang3, Marc Suchard4, Zhaoping Li3 and David Heber3

3 Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles, CA and 4 Departments of Biomathematics and Human Genetics, University of California, Los Angeles, CA

* To whom correspondence should be addressed. E-mail: nseeram{at}mednet.ucla.edu.

Ellagitannins (ETs) from pomegranate juice (PJ) are reported to have numerous biological properties, but their absorption and metabolism in humans are poorly understood. To investigate the pharmacokinetics of pomegranate ETs, 18 healthy volunteers were given 180 mL of PJ concentrate, and blood samples were obtained for 6 h afterwards. Twenty-four–hour urine collections were obtained on the day before (–1), the day of (0), and the day after (+1) the study. Ellagic acid (EA) was detected in plasma of all subjects with a maximum concentration of 0.06 ± 0.01 µmol/L, area under concentration time curve of 0.17 ± 0.02 (µmol · h) · L–1, time of maximum concentration of 0.98 ± 0.06 h, and elimination half-life of 0.71 ± 0.08 h. EA metabolites, including dimethylellagic acid glucuronide (DMEAG) and hydroxy-6H-benzopyran-6-one derivatives (urolithins), were also detected in plasma and urine in conjugated and free forms. DMEAG was found in the urine obtained from 15 of 18 subjects on d 0, but was not detected on d –1 or +1, demonstrating its potential as a biomarker of intake. Urolithin A-glucuronide was found in urine samples from 11 subjects on d 0 and in the urine from 16 subjects on d +1. Urolithin B-glucuronide was found in the urine of 3 subjects on d 0 and in the urine of 5 subjects on d +1. Urolithins, formed by intestinal bacteria, may contribute to the biological effects of PJ as they may persist in plasma and tissues and account for some of the health benefits noted after chronic PJ consumption. Whether genetic polymorphisms in EA-metabolizing enzymes (e.g., catechol-O-methyl transferase and glucuronosyl transferase) are related to variations in response to PJ remains to be established.





This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. B. Rettig, D. Heber, J. An, N. P. Seeram, J. Y. Rao, H. Liu, T. Klatte, A. Belldegrun, A. Moro, S. M. Henning, et al.
Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-{kappa}B-dependent mechanism
Mol. Cancer Ther., September 1, 2008; 7(9): 2662 - 2671.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2006 by American Society for Nutrition